ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 29.21.
| Share Price | ₹5,701.2 | Nov 11,2025 |
| Market Cap | ₹68,185.8 Cr | |
| Earnings-TTM | ₹2,334.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 29.21x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹68,185.8 Cr] as on Nov 11,2025
(/) Earnings [ ₹2,334.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 29.21x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 29.21 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 29.66x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 26.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 20.91x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALKEM LABORATORIES | 2,334.08 | 29.21 | 68,185.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 39.15 | 411,738.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 69.80 | 173,460.0 |
| CIPLA LTD | 5,453.86 | 22.44 | 122,361.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.50 | 129,476.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.67 | 101,101.0 |
| MANKIND PHARMA LTD | 1,767.06 | 51.86 | 91,642.7 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.98 | 94,389.8 |
| LUPIN LTD | 4,347.53 | 20.76 | 90,242.5 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.67 | 67,823.1 |
| ABBOTT INDIA LTD | 1,508.95 | 41.60 | 62,778.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.67x |
| Max industry PE | 69.80x |
| Median industry PE | 29.21x |
| Average industry PE | 35.60x |
You may also like the below Video Courses